WOUND TEST
Augustus Laboratories pioneers molecular diagnostics for the precise identification of diverse wound pathogens. Our state-of-the-art testing not only encompasses conventional open and deep tissue infections but also targets a comprehensive spectrum of specific conditions including impetigo, erysipelas, folliculitis, pyoderma, cellulitis, diabetic ulcers, actinomycetoma, animal bite wounds, and implant-associated infections. Using an E-swab specimen, our advanced molecular assays detect and characterize bacterial, viral, and fungal pathogens, offering unparalleled accuracy and rapid results crucial for tailored treatment strategies and improved patient outcomes.
AUGUSTUS LABORATORIES WOUND AND SKIN INFECTIOUS DISEASE
Augustus Laboratories leads the field in molecular diagnostics for infectious diseases, particularly in wound and skin infections. While traditional culture-based and serological methods have their merits, they often lack the precision and comprehensive insights provided by our advanced molecular PCR-based testing.
Our approach not only identifies a wide array of pathogens with high accuracy but also includes crucial antibiotic resistance profiling. This ensures that healthcare providers receive actionable insights swiftly, allowing for precise treatment decisions that minimize the risk of ineffective therapies and antibiotic resistance development.
In contrast to conventional methods that may lead to prolonged treatment durations and potential complications, our molecular diagnostics streamline the diagnostic process. This helps in avoiding unnecessary trial-and-error approaches and ensures timely interventions, ultimately improving patient outcomes.
By choosing Augustus Laboratories, healthcare providers benefit from cutting-edge technology that sets new standards in infectious disease testing, enhancing clinical confidence and optimizing patient care pathways. Our commitment to accuracy, speed, and comprehensive reporting empowers clinicians to deliver personalized treatment strategies that effectively combat infections and support better patient health.
AUGUSTUS LABORATORIES WOUND AND SKIN INFECTIOUS DISEASE:
BACTERIAL
- Acinetobacter baumannii complex
- Citrobacter sp
- Streptococcus pyogenes (Group A)
- Staphylococci Coag-Neg (epidermidis, haemolyticus, lugdunensis)
- Escherichia coli
- Enterobacter sp
- Enterococcus sp
- Klebsiella sp
- Morganella morganii
- Pseudomonas aeruginosa
- Providencia stuartii
- Proteus mirabilis
- Proteus vulgaris
- Serratia marcescens
- Staphylococcus aureus
- Streptococcus pneumoniae
- Actinomyces israelii
- Bacteroides fragilis
- Bartonella sp
- Clostridium perfringens, Clostridium septicum
- Corynebacterium Striatum
- Francisella tularensis
- Finegoldia magna
- Fusobacterium necrophorum
- Fusobacterium nucleatum
- Malassezia furfur
- Mycobacterium kansasii
- Mycobacterium intracellulare
- Nocardia asteroides
- Pasteurella multocida
- Propionibacterium acnes (Cutibacterium acnes)
FUNGAL
- Candida albicans
- Candida group (C.tropicalis, C. parapsilosis, Candida krusei, Candida glabrata)
ANTIBIOTIC RESISTANCE
- Tetracycline Resistance
- AmpC Betalactamase Class A and D Beta-lactamase
- Dihydrofolate and Sulfonamide Resistance
- ERM Macrolide Resistance
- Carbapenemase and Matallo-Betalactamase Resistance
- AmpC and ESBL
- KPC Carbapenemase
- MefA Macrolide Resistance
- Cfr Macrolide Resistance
- CTX-M Class A Betalactamase
- Quinolone Resistance
- Vancomycin Resistance
FUNGAL
- HSV1, HSV2
- Varicella zoster virus (VZV)
Augustus Laboratories leads the field in molecular diagnostics for infectious diseases, particularly in wound and skin infections. While traditional culture-based and serological methods have their merits, they often lack the precision and comprehensive insights provided by our advanced molecular PCR-based testing.
Key features of our testing program include:
- Comprehensive detection of a broad spectrum of pathogens without the need for reflex testing.
- Identification of 34 antibiotic-resistant genes, facilitating tailored treatment strategies.
- Utilization of highly precise PCR/RT-PCR methodologies, guaranteeing optimal accuracy.
- Reporting on all pathogens present in specimens, not limited to culturable ones.
- Swift turnaround time with results typically available the same day upon receipt of the specimen.
- Provision of individualized antibiotic treatment plans to streamline patient care.
- Wireless test reporting options with electronic medical record (EMR) integration for seamless workflow.
- In-network participation with most private and public healthcare plans, including Medicare and Medicaid.
By choosing Augustus Laboratories, healthcare providers benefit from advanced molecular diagnostics that deliver comprehensive, accurate, and timely results, empowering them to make informed treatment decisions and improve patient outcomes effectively.
Augustus Laboratories sets a new standard in wound pathogen testing with state-of-the-art PCR/RT-PCR technology. Unlike conventional methods that may miss pathogens or lack sensitivity, our molecular approach ensures comprehensive detection of a broad range of pathogens, including bacteria, viruses, and fungi. This method is not only highly sensitive, capable of detecting extremely low pathogen levels, but also identifies antibiotic resistance genes to tailor treatment effectively.
Our commitment to accuracy means clinicians receive actionable results rapidly, typically within 24-48 hours of sample receipt. This swift turnaround reduces treatment delays and potential complications associated with non-healing wounds, such as cellulitis and sepsis. By providing detailed reports that encompass all detected pathogens, not just culturable ones, Augustus Laboratories empowers healthcare providers with the insights needed for precise and proactive patient care.
Our commitment to accuracy means clinicians receive actionable results rapidly, typically within 24-48 hours of sample receipt. This swift turnaround reduces treatment delays and potential complications associated with non-healing wounds, such as cellulitis and sepsis. By providing detailed reports that encompass all detected pathogens, not just culturable ones, Augustus Laboratories empowers healthcare providers with the insights needed for precise and proactive patient care.
Experience the advantage of cutting-edge molecular diagnostics with Augustus Laboratories' Wound Pathogen Panel Test—setting the benchmark for rapid, precise diagnostics and personalized treatment plans in wound management.
Clinical Solution
Augustus Laboratories provides clinicians with state-of-the-art molecular methodologies for detecting, quantifying, and identifying resistance genes in pathogens. Our technology platform delivers rapid and precise results, integrating antibiotic resistance data alongside regional sensitivity profiles, medication costs, antibiotic efficacy, FDA guidelines, and personalized pharmacy recommendations.
This patient-centered approach empowers providers to make informed treatment decisions, mitigating risks such as inappropriate therapy, excessive costs, adverse drug events, and disease progression.
